NYSEARCA:IQSM NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) Price, Holdings, & News $39.41 +0.17 (+0.42%) As of 11:08 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest About NYLIM Candriam U.S. Mid Cap Equity ETF (NYSEARCA:IQSM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IQSM alerts:Sign Up Key Stats Today's Range$39.24▼$39.2450-Day Range$38.74▼$40.8852-Week Range$32.77▼$40.88Volume144 shsAverage Volume22,516 shsMarket Capitalization$354.61 millionAssets Under Management$364.97 millionDividend Yield1.04%Net Expense Ratio0.15%Aggregate RatingModerate Buy ETF Overview The Iq Candriam ESG U.S. Mid Cap Equity ETF (IQSM) is an exchange-traded fund that is based on the IQ Candriam ESG U.S. Mid Cap Equity index. The fund tracks a market cap-weighted index that provides exposure to US mid-cap stocks that meet environmental, social, and corporate governance criteria. IQSM was launched on Oct 25, 2022 and is managed by IndexIQ. Read More NYLIM Candriam U.S. Mid Cap Equity ETF ExpensesTypeIQSMMid Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.15%0.35%0.57%0.50%0.53%Other Expenses0.01%0.56%0.53%0.60%0.54%Total Expense0.16%0.55%0.75%0.75%0.73%Fee Waiver-0.01%-0.86%-0.67%-0.78%-0.68%Net Expense0.15%0.38%0.63%0.57%0.60% Receive IQSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NYLIM Candriam U.S. Mid Cap Equity ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IQSM ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com IQSM ETF - Frequently Asked Questions How have IQSM shares performed this year? NYLIM Candriam U.S. Mid Cap Equity ETF's stock was trading at $34.62 on January 1st, 2026. Since then, IQSM stock has increased by 13.8% and is now trading at $39.4060. How do I buy shares of NYLIM Candriam U.S. Mid Cap Equity ETF? Shares of IQSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerNew York Life Investments Fund NameNYLIM Candriam U.S. Mid Cap Equity ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IQSM Inception Date10/25/2022 Fund ManagerGreg Barrato, Francis Ok WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYLI Candriam U.S. Mid Cap Equity Index CategorySize and Style FocusMid Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings249 Fund Statistics Assets Under Management$364.97 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorNew York Life Investment Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest4,938 shs Miscellaneous Outstanding Shares8,999,000Beta1.06 Creation Fee$250.00 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report Top 10 IQSM HoldingsModerna (NASDAQ:MRNA)Holding Weight: 1.78%Revolution Medicines (NASDAQ:RVMD)Holding Weight: 1.49%Twilio (NYSE:TWLO)Holding Weight: 1.18%Okta (NASDAQ:OKTA)Holding Weight: 1.05%US Foods (NYSE:USFD)Holding Weight: 0.94%nVent Electric (NYSE:NVT)Holding Weight: 0.90%F5 (NASDAQ:FFIV)Holding Weight: 0.86%Guardant Health (NASDAQ:GH)Holding Weight: 0.83%Coeur Mining (NYSE:CDE)Holding Weight: 0.79%Roku (NASDAQ:ROKU)Holding Weight: 0.73%Full Holdings DetailsIQSM Sector ExposureIQSM Industry Exposure This page (NYSEARCA:IQSM) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our Partners“This is the Perfect Tech Stock”Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredThe national debt just passed $39 trillionThe U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...US Gold Bureau | SponsoredThis Gold Explorer Is Approaching Its Biggest Milestone YetA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...Equiscreen | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NYLIM Candriam U.S. Mid Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share NYLIM Candriam U.S. Mid Cap Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
